The Bio Report

Targeting a Multitude of CIN in Cancer Cells

01.03.2024 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Charles Hugh-Jones, CEO of Volastra, discusses chromosomal instability in cancer cells, how the company is developing a pipeline of therapies to exploit this, and its expanding relationships with Big Pharma .

More episodes from The Bio Report